Cancer patients who interact with an AI doctor before meeting their real-life consultant feel more knowledgeable and less stressed, according to research presented at ESTRO 2026.
Cancer patients who engage with an artificial intelligence (AI) avatar doctor prior to their consultation with a real-life physician report enhanced knowledge and reduced stress levels, according to findings from the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026). The study suggests that using AI as a pre-consultation tool can significantly improve patients' understanding of their condition and treatment options.
Dr. Maria Rodriguez, lead researcher at the Department of Radiation Oncology, explained, "Our research indicates that patients who interact with our AI avatar before seeing their oncologist feel more prepared and informed about their diagnosis and proposed treatments." She added, "This preliminary interaction can help alleviate anxiety and uncertainty, leading to a smoother and more effective consultation process."
The study involved 150 cancer patients across various stages of treatment. Participants were randomly assigned either an AI consultation or a traditional one with a human doctor. Those who interacted with the AI avatar reported feeling significantly more confident about their health status and treatment plan compared to those in the control group.
Dr. Rodriguez noted, "The AI avatar was designed to provide clear, concise information on common cancer-related topics such as symptoms, diagnosis methods, and potential treatments. This tailored approach helps patients feel better equipped to discuss their concerns with their real-life doctor."
Moreover, the research found that patients who used the AI consultation reported lower levels of stress compared to those in the traditional group. Dr. Rodriguez emphasized, "Reducing patient anxiety is crucial for effective treatment outcomes. By providing a platform where patients can ask questions and receive immediate feedback, we aim to create a more supportive environment."
The findings highlight the potential benefits of integrating AI into cancer care pathways. Dr. John Lee, a senior oncologist at the same institution, commented, "This study demonstrates that technology can play an important role in enhancing patient engagement and satisfaction. We look forward to further research exploring how AI can be used to improve other aspects of cancer treatment."
The results were presented at ESTRO 2026, one of the world's leading conferences on radiotherapy and oncology. The research team plans to continue developing the AI avatar to better simulate real-life consultations and provide more personalized support for cancer patients.
As Dr. Rodriguez concluded, "Our goal is to create a comprehensive digital health solution that complements traditional medical care, ultimately improving patient outcomes."
